Home/Filings/4/0001562180-23-000951
4//SEC Filing

Baird William D III 4

Accession 0001562180-23-000951

CIK 0001860782other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:59 PM ET

Size

8.8 KB

Accession

0001562180-23-000951

Insider Transaction Report

Form 4
Period: 2023-02-01
Baird William D III
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2023-02-01+107,143210,940 total
  • Award

    Stock Option (Right to buy)

    2023-02-01+50,00050,000 total
    Exercise: $13.20Exp: 2033-02-01Common Stock (50,000 underlying)
  • Award

    Common Stock

    2023-02-01+25,000103,797 total
Footnotes (3)
  • [F1]This restricted stock unit award vests over a four-year period at the rate of 25% on 01/01/2024, 25% on 01/01/2025, 25% on 01/01/2026, and 25% on 01/01/2027.
  • [F2]This restricted stock unit award vests over a three-year period at the rate of 40% on 01/01/2024, 40% on 01/01/2025, and 20% on 01/01/2026.
  • [F3]This stock option vests over a four-year period at the rate of 25% on 01/01/2024, and then in 36 equal monthly installments thereafter.

Issuer

2seventy bio, Inc.

CIK 0001860782

Entity typeother

Related Parties

1
  • filerCIK 0001547658

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:59 PM ET
Size
8.8 KB